Barclays’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Barclays’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-132,189	Closed	-$1.3M	–	5543
2022 Q3	$1.3M	Hold	132,189	–	–	﹤0.01%	2034
2022 Q2	$1.3M	Sell	132,189 -22,471	-15%	-$221K	﹤0.01%	2166
2022 Q1	$1.51M	Buy	+154,660	New	+$1.51M	﹤0.01%	2087

Barclays's SHAC Position: Q4 2022 in Review

Barclays sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 132,189 shares — an estimated $1.3M sold.

Barclays first reported a position in SHAC in Q1 2022 and held it in 3 quarters. The position peaked at $1.51M in Q1 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Barclays reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Barclays sold 132,189 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $1.3M.
Barclays first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2022 and held it in 3 quarters.
Barclays's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $1.51M in Q1 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.